Arizona paid nearly USD 27,000 for sodium thiopental, an anesthetic that has been used to carry out executions but is no longer manufactured by FDA-approved companies, the documents said. When the drugs arrived via British Airways at the Phoenix International Airport, they were seized by federal officials and have not been released, according to the documents obtained by The Associated Press.
"The department is contesting FDA's legal authority to continue to withhold the state's execution chemicals," state Department of Corrections spokesman Andrew Wilder said yesterday.
Arizona and other death penalty states have been struggling to obtain legal execution drugs for several years after European companies refused to sell the drugs, including sodium thiopental, that are needed to carry out executions.
States have had to change drug combinations or, in some cases, put executions on hold temporarily as they look for other options.
Arizona is not the only state that has tried to purchase drugs overseas. Earlier this year, Nebraska was told by the FDA that it could not legally import the drug it needed to carry out lethal injection after the governor said the state had obtained sodium thiopental from India.
And Texas yesterday said it had obtained a license from the US Drug Enforcement Administration to import sodium thiopental. However, Texas Department of Criminal Justice spokesman Jason Clark could not say whether the state had purchased or received any drugs from overseas.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
